Streamline Health Solutions, Inc. (STRM)
USD 2.28
(-0.71%)
USD 2.28
(-0.71%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -12.81 Million USD | 48.46% |
| 2022 | -6.24 Million USD | -11.63% |
| 2021 | -2.92 Million USD | -53.53% |
| 2020 | -4.79 Million USD | -686.94% |
| 2019 | -4.99 Million USD | -15.93% |
| 2018 | -2.93 Million USD | -44.28% |
| 2017 | 1.34 Million USD | 327.54% |
| 2016 | 551.63 Thousand USD | -86.16% |
| 2015 | 2.26 Million USD | 161.44% |
| 2014 | -6.06 Million USD | 20.5% |
| 2013 | -4.79 Million USD | -227.83% |
| 2012 | -2.34 Million USD | 267.27% |
| 2011 | 2.91 Million USD | -30.39% |
| 2010 | 1.45 Million USD | -66.38% |
| 2009 | 4.24 Million USD | 312.79% |
| 2008 | 1.03 Million USD | -31.93% |
| 2007 | 1.48 Million USD | -24.89% |
| 2006 | 2 Million USD | -37.65% |
| 2005 | 3.2 Million USD | 54.05% |
| 2004 | 2.08 Million USD | -38.52% |
| 2003 | 3.38 Million USD | -7.72% |
| 2002 | 3.67 Million USD | 35.75% |
| 2001 | 2.7 Million USD | 672.66% |
| 2000 | 909.12 Thousand USD | 73.76% |
| 1999 | -800 Thousand USD | 76.0% |
| 1998 | -7.8 Million USD | 46.04% |
| 1997 | -12.9 Million USD | -104.41% |
| 1996 | -5.5 Million USD | -3300.0% |
| 1995 | -200 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -371 Thousand USD | 0.0% |
| 2024 Q2 | -1.04 Million USD | 1.47% |
| 2023 FY | - USD | 48.46% |
| 2023 Q4 | -53 Thousand USD | 94.91% |
| 2023 Q3 | -1.04 Million USD | 31.29% |
| 2023 Q2 | -1.51 Million USD | 18.98% |
| 2023 Q1 | -1.87 Million USD | -4.7% |
| 2022 FY | - USD | -11.63% |
| 2022 Q2 | -2.07 Million USD | -23.91% |
| 2022 Q1 | -1.67 Million USD | -237.36% |
| 2022 Q3 | -2.17 Million USD | -4.68% |
| 2022 Q4 | -1.78 Million USD | 17.7% |
| 2021 FY | - USD | -53.53% |
| 2021 Q1 | -1.79 Million USD | -190.94% |
| 2021 Q3 | -3.29 Million USD | -84.8% |
| 2021 Q2 | -1.78 Million USD | 0.83% |
| 2021 Q4 | 1.21 Million USD | 136.97% |
| 2020 Q3 | -1.25 Million USD | -53.36% |
| 2020 FY | - USD | -686.94% |
| 2020 Q1 | -993 Thousand USD | 26.99% |
| 2020 Q2 | -819 Thousand USD | 17.52% |
| 2020 Q4 | -618 Thousand USD | 50.8% |
| 2019 Q1 | 777 Thousand USD | -33.45% |
| 2019 Q3 | 342 Thousand USD | 340.85% |
| 2019 Q2 | -142 Thousand USD | -118.28% |
| 2019 FY | - USD | -15.93% |
| 2019 Q4 | -1.36 Million USD | -497.66% |
| 2018 Q2 | -690.69 Thousand USD | -355.05% |
| 2018 FY | - USD | -44.28% |
| 2018 Q4 | 1.16 Million USD | 210092.45% |
| 2018 Q3 | -556.00 USD | 99.92% |
| 2018 Q1 | 270.8 Thousand USD | 350.2% |
| 2017 Q3 | 999.16 Thousand USD | 665.76% |
| 2017 Q2 | 130.48 Thousand USD | 116.2% |
| 2017 Q4 | 60.15 Thousand USD | -93.98% |
| 2017 FY | - USD | 327.54% |
| 2017 Q1 | -805.36 Thousand USD | -377.83% |
| 2016 Q3 | -519.3 Thousand USD | -170.84% |
| 2016 Q1 | 47.98 Thousand USD | -72.95% |
| 2016 Q2 | 733.09 Thousand USD | 1427.62% |
| 2016 Q4 | 289.87 Thousand USD | 155.82% |
| 2016 FY | - USD | -86.16% |
| 2015 Q3 | 1.16 Million USD | 5.3% |
| 2015 Q2 | 1.11 Million USD | 678.71% |
| 2015 FY | - USD | 161.44% |
| 2015 Q4 | 177.37 Thousand USD | -84.84% |
| 2015 Q1 | -191.95 Thousand USD | 94.01% |
| 2014 Q3 | -399.05 Thousand USD | 36.67% |
| 2014 Q1 | -1.07 Million USD | -84.42% |
| 2014 FY | - USD | 20.5% |
| 2014 Q2 | -630.16 Thousand USD | 41.34% |
| 2014 Q4 | -3.2 Million USD | -703.46% |
| 2013 Q4 | -582.47 Thousand USD | 86.72% |
| 2013 FY | - USD | -227.83% |
| 2013 Q3 | -4.38 Million USD | -4443.77% |
| 2013 Q2 | -96.52 Thousand USD | 93.01% |
| 2013 Q1 | -1.38 Million USD | -98.97% |
| 2012 Q2 | 740.63 Thousand USD | -51.2% |
| 2012 Q3 | 935.67 Thousand USD | 26.33% |
| 2012 Q4 | -694.21 Thousand USD | -174.19% |
| 2012 FY | - USD | 267.27% |
| 2012 Q1 | 1.51 Million USD | 1205.03% |
| 2011 Q4 | 116.3 Thousand USD | -88.13% |
| 2011 FY | - USD | -30.39% |
| 2011 Q3 | 980.15 Thousand USD | 36.01% |
| 2011 Q2 | 720.63 Thousand USD | 64.65% |
| 2011 Q1 | 437.68 Thousand USD | 1036.71% |
| 2010 Q2 | 843.77 Thousand USD | 331.91% |
| 2010 Q3 | 986.39 Thousand USD | 16.9% |
| 2010 Q4 | -46.72 Thousand USD | -104.74% |
| 2010 FY | - USD | -66.38% |
| 2010 Q1 | -363.84 Thousand USD | -114.8% |
| 2009 Q4 | 2.45 Million USD | 491.48% |
| 2009 Q3 | 415.55 Thousand USD | -40.33% |
| 2009 Q2 | 696.42 Thousand USD | 6.69% |
| 2009 FY | - USD | 312.79% |
| 2009 Q1 | 652.73 Thousand USD | 314.58% |
| 2008 Q1 | -123.62 Thousand USD | -109.31% |
| 2008 FY | - USD | -31.93% |
| 2008 Q2 | 278.05 Thousand USD | 324.91% |
| 2008 Q4 | 157.44 Thousand USD | -77.86% |
| 2008 Q3 | 711.09 Thousand USD | 155.74% |
| 2007 FY | - USD | -24.89% |
| 2007 Q4 | 1.32 Million USD | 140.86% |
| 2007 Q3 | 551.1 Thousand USD | 213.83% |
| 2007 Q2 | -484.16 Thousand USD | -546.23% |
| 2007 Q1 | 108.49 Thousand USD | -85.37% |
| 2006 Q2 | 710.21 Thousand USD | 80.96% |
| 2006 FY | - USD | -37.65% |
| 2006 Q4 | 741.54 Thousand USD | 373.55% |
| 2006 Q3 | 156.59 Thousand USD | -77.95% |
| 2006 Q1 | 392.46 Thousand USD | -82.89% |
| 2005 Q3 | -100.71 Thousand USD | -111.03% |
| 2005 Q2 | 912.69 Thousand USD | 781.35% |
| 2005 FY | - USD | 54.05% |
| 2005 Q1 | 103.55 Thousand USD | -92.95% |
| 2005 Q4 | 2.29 Million USD | 2377.18% |
| 2004 Q1 | 247.44 Thousand USD | -79.79% |
| 2004 Q3 | 155.57 Thousand USD | -26.63% |
| 2004 Q4 | 1.46 Million USD | 843.56% |
| 2004 Q2 | 212.04 Thousand USD | -14.31% |
| 2004 FY | - USD | -38.52% |
| 2003 Q1 | 19.35 Thousand USD | -98.39% |
| 2003 Q4 | 1.22 Million USD | -0.15% |
| 2003 Q3 | 1.22 Million USD | 33.61% |
| 2003 Q2 | 917.9 Thousand USD | 4642.21% |
| 2003 FY | - USD | -7.72% |
| 2002 Q2 | 820.64 Thousand USD | 16.33% |
| 2002 Q1 | 705.44 Thousand USD | -16.84% |
| 2002 Q3 | 942.88 Thousand USD | 14.9% |
| 2002 Q4 | 1.2 Million USD | 27.54% |
| 2002 FY | - USD | 35.75% |
| 2001 Q1 | 653 Thousand USD | -24.22% |
| 2001 FY | - USD | 672.66% |
| 2001 Q3 | 1.16 Million USD | 2612.3% |
| 2001 Q2 | 42.78 Thousand USD | -93.45% |
| 2001 Q4 | 848.33 Thousand USD | -26.9% |
| 2000 Q4 | 861.7 Thousand USD | 45.75% |
| 2000 FY | - USD | 73.76% |
| 2000 Q1 | -454.29 Thousand USD | -351.75% |
| 2000 Q3 | 591.23 Thousand USD | 599.63% |
| 2000 Q2 | -89.53 Thousand USD | 93.45% |
| 1999 Q2 | -700 Thousand USD | 0.0% |
| 1999 Q1 | -700 Thousand USD | 56.25% |
| 1999 FY | - USD | 76.0% |
| 1999 Q4 | 500 Thousand USD | -300.0% |
| 1999 Q3 | 184.06 Thousand USD | 128.57% |
| 1998 Q3 | -1.3 Million USD | 22.22% |
| 1998 Q2 | -2 Million USD | 37.93% |
| 1998 Q1 | -2.8 Million USD | 23.68% |
| 1998 FY | - USD | 46.04% |
| 1998 Q4 | -1.6 Million USD | -14.29% |
| 1997 Q4 | -3.6 Million USD | -22.58% |
| 1997 Q1 | -3 Million USD | -3.13% |
| 1997 FY | - USD | -104.41% |
| 1997 Q3 | -2.8 Million USD | 18.42% |
| 1997 Q2 | -3.5 Million USD | -15.15% |
| 1996 Q1 | -700 Thousand USD | 74.07% |
| 1996 FY | - USD | -3300.0% |
| 1996 Q3 | -1.6 Million USD | -110.0% |
| 1996 Q4 | -2.8 Million USD | -52.38% |
| 1996 Q2 | -500 Thousand USD | -42.86% |
| 1995 Q4 | -2.7 Million USD | -485.71% |
| 1995 Q2 | 1.2 Million USD | 200.0% |
| 1995 Q3 | 700 Thousand USD | -41.67% |
| 1995 FY | - USD | 0.0% |
| 1995 Q1 | 400 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ontrak, Inc. | -14.41 Million USD | 11.099% |
| iCoreConnect Inc. | -11.87 Million USD | -7.884% |
| Augmedix, Inc. | -17.68 Million USD | 27.515% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 103.667% |
| CareCloud, Inc. | -31.29 Million USD | 59.041% |
| CareCloud, Inc. | -31.29 Million USD | 59.041% |
| HealthEquity, Inc. | 282.41 Million USD | 104.538% |
| Inovalon Holdings, Inc. | 186.56 Million USD | 106.87% |
| Nutex Health, Inc. | -14.58 Million USD | 12.107% |
| OneMedNet Corporation | -11.97 Million USD | -7.061% |
| Progyny, Inc. | 64.46 Million USD | 119.881% |
| Omnicell, Inc. | 60.69 Million USD | 121.117% |
| Renalytix Plc | -28.52 Million USD | 55.065% |
| Schrödinger, Inc. | -171.89 Million USD | 92.544% |
| Simulations Plus, Inc. | 6.13 Million USD | 309.036% |
| SOPHiA GENETICS SA | -70.7 Million USD | 81.873% |
| Minerva Surgical, Inc. | -20.07 Million USD | 36.153% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 100.36% |
| Sharecare, Inc. | -67.25 Million USD | 80.944% |
| Aclarion, Inc. | -4.14 Million USD | -209.534% |
| CareMax, Inc. | -590.46 Million USD | 97.829% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | -142.955% |
| Forian Inc. | 2.75 Million USD | 565.987% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | -142.955% |
| HeartBeam, Inc. | 675 Thousand USD | 1998.667% |
| GeneDx Holdings Corp. | -136.46 Million USD | 90.608% |
| SCWorx Corp. | -3.97 Million USD | -222.44% |
| Definitive Healthcare Corp. | -241.22 Million USD | 94.687% |
| 10x Genomics, Inc. | -205.11 Million USD | 93.752% |
| Zhongchao Inc. | -4.9 Million USD | -161.425% |
| Accolade, Inc. | -71.19 Million USD | 81.998% |
| MSP Recovery, Inc. | -69.22 Million USD | 81.485% |
| R1 RCM Inc. | 426.2 Million USD | 103.007% |
| Spok Holdings, Inc. | 26.29 Million USD | 148.736% |
| Privia Health Group, Inc. | 27.18 Million USD | 147.149% |
| EUDA Health Holdings Limited | -8.3 Million USD | -54.403% |
| TruBridge, Inc. | -15.39 Million USD | 16.731% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 103.667% |
| Sharecare, Inc. | -67.25 Million USD | 80.944% |
| Health Catalyst, Inc. | -66.46 Million USD | 80.717% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 111.777% |
| Premier, Inc. | 286.08 Million USD | 104.48% |
| HealthStream, Inc. | 59.58 Million USD | 121.508% |
| Certara, Inc. | 23.84 Million USD | 153.749% |
| GeneDx Holdings Corp. | -136.46 Million USD | 90.608% |
| Ontrak, Inc. | -14.41 Million USD | 11.099% |
| SHL Telemedicine Ltd. | 3.28 Million USD | 490.314% |
| CareCloud, Inc. | -31.29 Million USD | 59.041% |
| EUDA Health Holdings Limited | -8.3 Million USD | -54.403% |
| HeartBeam, Inc. | 675 Thousand USD | 1998.667% |
| Mangoceuticals, Inc. | -9.18 Million USD | -39.493% |
| CareMax, Inc. | -590.46 Million USD | 97.829% |
| Healthcare Triangle, Inc. | -4.1 Million USD | -212.281% |
| National Research Corporation | 45.98 Million USD | 127.87% |
| Aclarion, Inc. | -4.14 Million USD | -209.534% |
| OptimizeRx Corporation | -21.3 Million USD | 39.855% |